|
Volumn 355, Issue 22, 2006, Pages 2278-2281
|
Osteonecrosis of the jaw - Do bisphosphonates pose a risk?
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALENDRONIC ACID;
ANALGESIC AGENT;
ANTIBIOTIC AGENT;
ANTINEOPLASTIC AGENT;
BACTERICIDE;
BISPHOSPHONIC ACID DERIVATIVE;
CLODRONIC ACID;
CORTICOSTEROID;
CYCLOHEXIDINE;
ETIDRONIC ACID;
HYDROGEN PEROXIDE;
IBANDRONIC ACID;
PAMIDRONIC ACID;
RISEDRONIC ACID;
ZOLEDRONIC ACID;
ANTIANGIOGENIC ACTIVITY;
BONE METASTASIS;
BONE NECROSIS;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CORTICOSTEROID THERAPY;
DEBRIDEMENT;
DENTAL SURGERY;
DISEASE PREDISPOSITION;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG STRUCTURE;
FEVER;
FLU LIKE SYNDROME;
GASTROINTESTINAL SYMPTOM;
HUMAN;
HYPERCALCEMIA;
INCIDENCE;
MOUTH HYGIENE;
MOUTH INJURY;
MYALGIA;
MYELOMA;
OSSIFICATION;
OSTEOLYSIS;
OSTEOPOROSIS;
PAGET BONE DISEASE;
PERIODONTITIS;
PRIORITY JOURNAL;
REVIEW;
STRUCTURE ACTIVITY RELATION;
TOOTH DISEASE;
TREATMENT DURATION;
BONE NEOPLASMS;
CAUSALITY;
DIPHOSPHONATES;
HUMANS;
INFUSIONS, INTRAVENOUS;
JAW DISEASES;
OSTEONECROSIS;
OSTEOPOROSIS;
SURGERY, ORAL;
TOOTH DISEASES;
|
EID: 33751528987
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMp068157 Document Type: Review |
Times cited : (243)
|
References (5)
|